Investor Relations Waleed Hassanein – President and Chief Executive Officer Stephen Gordon – Chief Financial Officer Conference Call Participants Allen Gong – JPMorgan William Plovanic – Canaccord ...

Investing.com -- TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in European markets that are expected to delay the company ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Humacyte (HUMA – Research Report) today and set a price target of $10.00. The company’s shares closed yesterday at $4.86. Jennings ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of $100.00. The company’s shares closed yesterday at $83.99.

TD Cowen has maintained a Hold rating on Moderna shares (NASDAQ: NASDAQ:MRNA), with a consistent price target of $60.00. The firm's update came ahead of the biotech sector's third-quarter earnings ...

TD Cowen has shown a modest increase in confidence in Lyft Inc. (NASDAQ: NASDAQ:LYFT), adjusting the price target slightly upward to $16 from the previous $15 while maintaining a Hold rating on ...

Investing.com -- TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in European markets that are expected to delay the company’s ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

SolarEdge Technologies (NASDAQ:SEDG) -4.2% in Monday's trading after TD Cowen downgraded shares to Hold from Buy with a $16 price target, slashed from $35, citing deteriorating demand in Europe ...

Fintel reports that on October 29, 2024, TD Cowen downgraded their outlook for Tapestry (LSE:0LD5) from Buy to Hold. As of October 22, 2024, the average one-year price target for Tapestry is 49.50 ...

On Monday, TD Cowen maintained a Hold rating on VF Corp (NYSE:VFC), with a consistent price target of $16.00. The stance comes amid investor and analyst uncertainty regarding the company's sales and ...